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1. Introduction 
The relationship between liver (L-type) and 
erythrocyte pyruvate kinase remains asubject of 
discussion. It has been previously demonstrated that 
these enzymes are kinetically [ 1,2] and immunologl- 
tally [3-51 related. In some cases liver (Ltype) 
pyruvate kinase from patients with hereditary ery- 
throcyte pyruvate kinase deficiency was shown to 
be defective [2,6-81. Erythrocyte and L-type 
enzymes, however, can be distinguished by their 
electrophoretic mobilities [2,9] . Some authors [9] 
have suggested that erythrocyte nzyme might be 
a hybrid between Ltype and non-L-type subunits: 
the demonstration by Peterson et al. [lo] that, by 
sodium dodecylsulphate-acrylamlde gel electro- 
phoresis, erythrocyte pyruvate kinase was resolved 
into two distinct bands with similar mobility, support- 
ed this assumption. 
We have purified erythrocyte nzyme by a new 
method, previously reported [Ill. The crucial step 
of this purification procedure was an affinity chromato- 
graphy on a bluedextran Sepharose 4 B column, with 
selective lution by fructose-l ,6diphosphate. Under 
some conditions, red cell pyruvate kinase was eluted 
from the blue-dextran Sepharose column in two peaks. 
The purpose of this work was to study the nature 
of those two molecular forms of the erythrocyte 
enzyme in relation to the L-type enzyme from liver. 
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We have been able to prove that one of the 
erythrocyte forms was a homotetramer composed of 
4 identical Ltype subunits, while the other one was 
a hybrid composed of 2 L-type subunits and 2 sub- 
units with a slightly higher molecular weight. The 
specific activity of this latter form was half that of 
the former. This heterotetramer could be activated 
and transformed into a homotetramer similar to 
L-type enzyme under the influence of a limited 
proteolysis by trypsin. 
From these results it might be speculated that 
erythrocyte pyruvate kinase might be synthesized as 
a precursor enzyme whose postsynthetic partial 
proteolysis could lead to a progressive transformation 
into L-type enzyme; such a modification seems to 
be associated with an increase of the catalytic efticien- 
cy of pyruvate kinase. 
2. Materials and methods 
Ion-exchangers, cyanogen bromide-activated 
Sepharose 4 B and bluedextran were supplied by 
Pharmacia. The substrates for the enzymatic reaction 
and the intermediate enzymes were furnished by 
Boehringer-Mannheim. Trypsin (TRTPCK) came 
from Worthington Biochemical Corporation. Acryl- 
amide and sodium dodecylsulphate-a&amide gel 
electrophoresis was performed as reported elsewhere 
[ 121. Slab-gel electrophoresis was performed accord- 
ing to the methods described by Imamura et al. [9 ] , 
slightly modified in that the gel was 4% acrylamide 
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instead of 3.34% and the pH 8 instead of pH 8.2. 
The enzymes were focused in acrylamide-ampholine 
gels as described in ref. [ 121 . The gels were stained 
either for proteins, by Coomassie Blue, or for pyruvate 
kinase activity; in the latter case the enzymatic 
activity was revealed either by defluorescence under 
ultraviolet, or by positive staining, via the hexokinase 
and glucosed-phosphate dehydrogenase reactions [ 131. 
The molecular weight of the whole molecules and 
dissociated subunits of the erythrocyte enzymes have 
been determined by gel filtration and by sodium 
dodecylsulphate-acrylamide gel electrophoresis, 
respectively as previously described for L-type pyru- 
vate kinase [12] . 
The tryptic hydrolysis was performed at room 
temperature: 100 pg pure pyruvate kinase were 
diluted in 500 1.t1 50 mM Tris-chloride buffer, pH 7.3, 
containing 100 mM KCl, 4 mM MgCl*, 0.1 mM 
P-mercaptoethanol and 500 mM sucrose, then incu- 
bated either alone or with 20 /.fg trypsin. Tryptic 
digestion was stopped after various incubation times 
by adding 2 mM diisopropylfluorophosphate to the 
reaction mixtures. L-Type pyruvate kinase from 
human liver was purified to homogeneity by a proce- 
dure whose last step was identical with that described 
for the red cell enzyme (i.e., an affinity chromato- 
graphy on blue-dextran Sepharose 4 B column with 
elective elution by fructose-l ,6diphosphate [ 141. 
Enzyme activity was measured at 30°C in Tris- 
chloride buffer pH 8, according to Beutler [ 151 and 
Blume et al. [16] . 
3. Results 
The elution pattern of erythrocyte pyruvate kinase 
from the last step of purification is shown in fig.1. 
The active fractions from each peak were collected 
separately. Specific activity of the erythrocyte enzyme 
from the first peak (designated as red cell pyruvate 
kinase I) was 300 IU/mg protein, whereas specific 
activity of the enzyme from the second peak (pyruvate 
kinase II) was only 150 IU/mg protein. Acrylamide gel 
electrophoresis, in slab-gels or in disc-gels (fig.2) 
showed that each preparation contained a single 
molecular form, enzyme I exhibiting a more anodic 
migration than enzyme II. 
Isoelectrofocusing in acrylamide-ampholine gel, in 
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Fig.1. Elution of erythrocyte pyruvate kinase from the blue- 
dextran Sepharose 4 B column. The preparation obtained 
after the second step of the purification procedure described 
in ref. [ 111 was desalted by chromatography on a Sephadex 
G-25 column equilibrated with a 50 mM Tris-chloride buffer, 
pH 7.5, containing 1 mM EDTA, 2 mM p-mercaptoethanol, 
1 mM e-aminocaproic acid and 40 mM NaCl, then applied to 
the dextran-blue Sepharose 4 B column equilibrated with the 
same buffer. The column was then washed with a 40 mM 
Tris-chloride buffer, pH 7.5, containing 60 mM KC1 and the 
same protectors as above; elution was initiated by adding 
0.1 mM fructose-l ,5diphosphate to this buffer. (--a- a--) 
Pyruvate kinase activity, (- ) absorbance at 280 nm. 
tubes or in thin layer, confirmed that isoelectric point 
of enzyme I was slightly higher (i.e., more alkaline) 
than that of enzyme II. It should be noted that L-type 
pyruvate kinase from liver and erythrocyte pyruvate 
kinase I were similar, according to their electropho- 
retie mobility in various conditions and their isoelectro- 
focusing patterns. 
As previously described for L-type and erythrocyte 
pyruvate kinase [ 11 ,121 the molecular weight of 
enzyme I and enzyme II estimated by gel filtration 
was about 220 000-240 000. Sodium dodecyl- 
sulphate-acrylamide gel electrophoresis (tig.3) 
revealed a single protein band for enzyme I. This 
band corresponds to a subunit having exactly the 
same migration (i.e., the same mol. wt N 60 000) as 
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Fig.2. Acrylamide gel electrophoresis of red cell pyruvate 
klnase I and II. Gels were 4% (1 and 2), 6% (1’ and 2’) and 
8% (1” and 2”) acrylamide (w/v), in 40 mM Tris-lycine 
buffer, pH 8.7, containing 1 mM EDTA. 20 pg of protein 
were deposited at the top of the gels. Protein were stained 
with Coomassie Blue. 
the L-type subunit. By contrast enzyme II showed, 
by sodium dodecylsulphate-acrylamide gel electro- 
phoresis, two distinct protein bands: one being 
identical with that found with L-type pyruvate 
kinase or with red cells pyruvate kinase I, the other 
showing a slower migration (i.e., with a molecular 
weight slightly higher than for L-type subunit). 
The mild treatment by trypsin, as described in 
Materials and methods, resulted in enzyme activity 
and electrophoretic mobility changes of red cell 
pyruvate kinase II, whereas the characteristics of 
L-type enzyme or enzyme I were not significantly 
affected. Enzyme activity of red cell enzyme II 
increased progressively up to 160% of the initial 
activity; its electrophoretic mobility in acrylamide 
slab-gel became identical with that of enzyme I. 
Finally, the additional protein band shown by sodium 
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Fig.3. Sodium dodecylsulphate-acrylamide gel electro- 
phoresis of the trypsin-treated and non-treated forms of ery- 
throcyte pyruvate kinases. (1, 1’) Red cell pyruvate kinase I, 
non-treated (1) and treated (1’). (2, 2’) Red cell pyruvate 
kinase II, non-treated (2) and treated (2’). (3, 3’) Mixture of 
L-type pyruvate kinase from liver and of erythrocyte pyru- 
vate kinase II, non-treated (3) and treated (3’). This latter 
experiment shows that the ‘light’ subunit of the red cell 
enzyme II has a migration (i.e., a molecular weight) identical 
with that of the L-type subunits, and that the treatment by 
trypsin converts the ‘heavy’ subunit ‘L” into a subunit having 
a molecular weight identical with that of the L-type subunits. 
dodecylsulphate-a&amide gel electrophoresis 
(tig.3) (i.e., the ‘heavy’ subunit) disappeared. 
Molecular weight of the undissociated trypsinized 
enzyme II was similar to that of the untreated 
enzyme. 
In other words, after treatment by trypsin, enzyme 
II was composed from four identical subunits having 
a molecular weight identical with that of the L-type 
subunits. 
4. Discussion 
The results reported above establish clearly that at 
least two forms of pyruvate kinase can be purified 
from human erythrocytes. The first one is a homo- 
tetramer composed of 4 identical L-type subunits, 
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and may be designated as ‘L4’; the second form is a 
heterotetramer tentatively designated as ‘L2Lf2’. 
lytic activation of the precursor pyruvate kinase 
molecules is especially active in liver. 
In a previous paper Peterson et al. [IO] have also 
demonstrated :that , in some cases, erythrocyte 
pyruvate kinase could be dissociated by sodium 
dodecylsulphate-acrylamide gel electrophoresis into 
two protein bands with similar mobilities. These 
authors, however, hypothesized that one of these 
bands might correspond to an M-type subunit. We 
have recently shown [ 171 that there was no inter- 
action between anti-leukocyte (M2) serum and 
erythrocyte enzyme, while Lincoln et al. [18] proved 
that anti-muscle (Ml) pyruvate kinase serum did not 
cross-react with red cell pyruvate kinase. 
In conclusion, it seems that erythrocyte pyruvate 
kinase is genetically identical to L-type enzyme from 
liver. 
The pyruvate kinase enzyme could be synthesized 
in a ‘proenzymatic’ form requiring a partial proteolysis 
to reach whole activity. This phenomenon could be 
especially active in liver. 
Tms paper demonstrates that, under the influence 
of a partial proteolysis by trypsin, the ‘L” subunit 
can be changed into a form which cannot be distin- 
guished from L-type subunit, by electrophoresis of 
the whole or dissociated molecules. We have demon- 
strated in another work (to be published) that, when 
studied with an anti L-type pyruvate kinase serum, 
the L’ and L subunits seemed to be antigenetically 
identical. Consequently it can be speculated that the 
L’ subunit is the precursor of L-type subunit, the 
conversion of L’ into L subunit involving the cleavage 
of a peptide located to an extremity of the molecule. 
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